Biomedical research has been revolutionized by the introduction of many CRISPR-Cas systems that induce programmable edits to nearly any gene in the human genome.
CRISPR
New gene editing tool driving stem cell services and discovery
A new gene editing service provides researchers on campus with genetically engineered pluripotent stem cell lines derived using CRISPR-Cas9. The UW-Madison iPSC Reprogramming and Human Stem Cell Gene Editing Service is co-operated by the Waisman …
Cell transplant treats Parkinson’s in mice under control of designer drug
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Waisman researchers win an inaugural UW2020 award
An innovative project led by Waisman Center researchers Anita Bhattacharyya and Su-Chun Zhang is one of fourteen research initiatives that have been chosen for the first round of funding by the University of Wisconsin-Madison Office of the Vice Chancellor for Research and Graduate Education for the UW2020: WARF Discovery Initiative.
Expert: Editing stem cell genes will “revolutionize” biomedical research
Applying a dramatically improved method for “editing” genes to human stem cells, University of Wisconsin-Madison neuroscientist and Waisman Center investigator Su-Chun Zhang has shown a new way to silence genes in stem cells and their progeny at any stage of development.